Thyroid News

Japanese euthyroid adults who report smoking have a lower thyroid-stimulating hormone level compared with nonsmokers independent of age, sex, race and iodine status, according to findings published in the Journal of the Endocrine Society.

Women exposed to air pollution during the first trimester of pregnancy are more likely to experience mild thyroid dysfunction throughout pregnancy, compared with unexposed women, according to findings published in JAMA Network Open.

SAN FRANCISCO — Rather than thinking of ophthalmic Graves’ disease as one entity classified as “mild” or “moderate to severe,” William R. Nunery, MD, FACS, told colleagues at the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting that thyroid eye disease should be considered as two separate subtypes.

Among adults with type 2 diabetes, those who trend toward the higher end of the normal range for thyroid-stimulating hormone may be less likely to experience a stroke, according to findings published in Diabetes Research and Clinical Practice.

We should not automatically accept that controversy in one area should serve as a rationale for doing nothing in another.

Subclinical hypothyroidism is a common diagnosis, present in approximately 3% to 4% of reproductive-age women. Although a mild form of hypothyroidism — defined as elevated thyroid-stimulating hormone with normal free thyroxine levels — the condition has been associated with infertility, increased risk for adverse pregnancy and neonatal outcomes, and possibly with increased risk for neurocognitive deficits in offspring.

Children of mothers who received thyroid hormone therapy during pregnancy showed no difference in language and communication skill at age 8 years when compared with children of mothers who did not receive thyroid HT, according to findings published in JAMA Network Open.

SAN FRANCISCO — At the American Society of Ophthalmic Plastic and Reconstructive Surgery meeting, Raymond Douglas, MD, PhD, of Cedars-Sinai Medical Center, discusses new data from the phase 3 OPTIC confirmatory clinical trial.

SAN DIEGO — Understanding which drugs and drug classes contribute to adverse bone effects, including bone loss and fractures, may be extremely useful for rheumatologists and their patients, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

Takeda recently announced it is issuing a U.S. recall for all doses of its parathyroid hormone injection due to potential rubber particulate contamination originating from the rubber septum of the product’s cartridge, according to a statement released by the FDA.